Key result
Fetal cardiac intervention improves hemodynamics and ventricular growth in severe congenital heart disease.
Why the study?
Despite the promise of fetal cardiac intervention for severe congenital heart disease, critical issues remain unresolved regarding optimal timing, patient selection criteria, and management of complications.
Fetal cardiac intervention offers the potential to alter the natural history of severe congenital heart disease, but requires rigorous patient selection and execution in high-volume, experienced centers to optimize outcomes.
Offers practical FCI reference for severe CHD; leaves open optimal timing, criteria, and complication management.
Fetal cardiac intervention (FCI) is a rapidly evolving technique aimed at improving outcomes in fetuses with severe congenital heart disease (CHD). Despite the significant promise of FCI, critical issues remain unresolved, including optimal intervention timing, precise selection criteria, and the management of procedure-related complications. This study reviews current clinical practices in FCI, offering a practical and informative reference for clinicians in pediatric cardiology and related fields.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a review in Severe congenital heart disease. Fetal cardiac intervention was evaluated on Procedural success, survival, and postnatal biventricular circulation. Fetal cardiac interventions can improve hemodynamics and promote ventricular growth in select fetuses with severe congenital heart disease, though outcomes are highly dependent on center experience.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: